Regulatory

RSS

Ragwitek sublingual immunotherapy approved by FDA for hay fever

April 22, 2014

Lilly's VEGF-inhibiting monoclonal antibody approved for gastric cancer

April 22, 2014

Dyax receives FDA approval to expand the use of Kalbitor

April 7, 2014

Subcutaneous MabThera approved in Europe for two forms of NHL

March 31, 2014

Albiglutide approved in Europe for type 2 diabetes

March 27, 2014

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Tofogliflozin hydrate approved for type 2 diabetes in Japan

March 26, 2014

Kaketsuken announces Japanese approval of cell culture pandemic influenza vaccine

March 26, 2014

Japanese approval of Lusefi for type 2 diabetes

March 25, 2014

Takelda combination tablets approved in Japan

March 25, 2014